Excellentis Clinical trial Consultants

George 6530

0 studies enrolling now · 3 studies all time

What they study most

Early Breast Cancer, Lupus Erythematosus, Systemic, Systemic Lupus Erythematosus

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early